Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM134 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HMGA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOTAIRM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSC22D2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAQR9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BARD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TXNDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DKFZP434L187 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FAM217A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF215 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM259 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD21L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on